Literature DB >> 18183000

Fractured European market undermines biosimilar launches.

Nuala Moran.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18183000     DOI： 10.1038/nbt0108-5

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

Review 1.  Are biosimilars the next tool to guarantee cost-containment for pharmaceutical expenditures?

Authors:  María-Isabel Farfan-Portet; Sophie Gerkens; Isabelle Lepage-Nefkens; Irmgard Vinck; Frank Hulstaert
Journal:  Eur J Health Econ       Date:  2013-11-23

2.  Biosimilars: company strategies to capture value from the biologics market.

Authors:  Bruno Calo-Fernández; Juan Leonardo Martínez-Hurtado
Journal:  Pharmaceuticals (Basel)       Date:  2012-12-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.